HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.

AbstractAIMS/HYPOTHESIS:
Autotaxin is a lysophospholipase D that is secreted by adipocytes and whose expression is substantially up-regulated in obese, diabetic db/db mice. The aim of the present study was to depict the physiopathological and cellular mechanisms involved in regulation of adipocyte autotaxin expression.
METHODS:
Autotaxin mRNAs were quantified in adipose tissue from db/db mice (obese and highly diabetic type 2), gold-thioglucose-treated (GTG) mice (highly obese and moderately diabetic type 2), high-fat diet-fed (HFD) mice (obese and moderately diabetic type 2), streptozotocin-treated mice (thin and diabetic type 1), and massively obese humans with glucose intolerance.
RESULTS:
When compared to non-obese controls, autotaxin expression in db/db mice was significantly increased, but not in GTG, HFD, or streptozotocin-treated mice. During db/db mice development, up-regulation of autotaxin occurred only 3 weeks after the emergence of hyperinsulinaemia, and simultaneously with the emergence of hyperglycaaemia. Adipocytes from db/db mice exhibited a stronger impairment of insulin-stimulated glucose uptake than non-obese and HFD-induced obese mice. Autotaxin expression was up-regulated by treatment with TNFalpha (insulin resistance-promoting cytokine), and down-regulated by rosiglitazone treatment (insulin-sensitising compound) in 3T3F442A adipocytes. Finally, adipose tissue autotaxin expression was significantly up-regulated in patients exhibiting both insulin resistance and impaired glucose tolerance.
CONCLUSIONS/INTERPRETATION:
The present work demonstrates the existence of a db/db-specific up-regulation of adipocyte autotaxin expression, which could be related to the severe type 2 diabetes phenotype and adipocyte insulin resistance, rather than excess adiposity in itself. It also showed that type 2 diabetes in humans is also associated with up-regulation of adipocyte autotaxin expression.
AuthorsJ Boucher, D Quilliot, J P Pradères, M F Simon, S Grès, C Guigné, D Prévot, G Ferry, J A Boutin, C Carpéné, P Valet, J S Saulnier-Blache
JournalDiabetologia (Diabetologia) Vol. 48 Issue 3 Pg. 569-77 (Mar 2005) ISSN: 0012-186X [Print] Germany
PMID15700135 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • Multienzyme Complexes
  • Deoxyglucose
  • Phosphoric Diester Hydrolases
  • Phosphodiesterase I
  • alkylglycerophosphoethanolamine phosphodiesterase
  • Pyrophosphatases
  • Glucose-6-Phosphate Isomerase
Topics
  • Adipocytes (enzymology, physiology)
  • Animals
  • Biological Transport
  • Deoxyglucose (pharmacokinetics)
  • Diabetes Mellitus, Experimental (enzymology, physiopathology)
  • Diabetes Mellitus, Type 2 (enzymology, physiopathology)
  • Gene Expression Regulation
  • Gene Expression Regulation, Enzymologic
  • Glucose-6-Phosphate Isomerase (genetics)
  • Glycoproteins (genetics)
  • Humans
  • Insulin Resistance (physiology)
  • Lipectomy
  • Mice
  • Mice, Inbred C57BL
  • Multienzyme Complexes (genetics)
  • Obesity (physiopathology)
  • Phosphodiesterase I
  • Phosphoric Diester Hydrolases (genetics)
  • Pyrophosphatases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: